Xiaobing Ye

1.9k total citations
36 papers, 1.6k citations indexed

About

Xiaobing Ye is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaobing Ye has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Immunology and 14 papers in Cancer Research. Recurrent topics in Xiaobing Ye's work include Immune Response and Inflammation (9 papers), NF-κB Signaling Pathways (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Xiaobing Ye is often cited by papers focused on Immune Response and Inflammation (9 papers), NF-κB Signaling Pathways (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers). Xiaobing Ye collaborates with scholars based in China, United States and France. Xiaobing Ye's co-authors include Shu Fang Liu, Asrar B. Malik, Dongmei Song, Jianqiang Ding, Harly Greenberg, Chen Guo-qian, Xiaozhou Zhou, Aung Htoo, Darrell M. Wilson and Gang Liu and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Xiaobing Ye

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Ye China 19 552 478 403 325 272 36 1.6k
Juan Carlos Calvo Argentina 22 570 1.0× 337 0.7× 256 0.6× 410 1.3× 145 0.5× 79 2.0k
Mayumi Suzuki Japan 23 485 0.9× 232 0.5× 237 0.6× 502 1.5× 360 1.3× 82 2.0k
Nektarios Barabutis United States 28 905 1.6× 254 0.5× 276 0.7× 210 0.6× 308 1.1× 98 2.0k
Ying Yu China 23 412 0.7× 244 0.5× 215 0.5× 223 0.7× 153 0.6× 50 1.5k
Song‐Yang Zhang China 21 754 1.4× 322 0.7× 216 0.5× 277 0.9× 110 0.4× 32 1.6k
Larissa Prata United States 10 569 1.0× 420 0.9× 114 0.3× 962 3.0× 234 0.9× 15 1.8k
Yan Ge China 26 805 1.5× 317 0.7× 114 0.3× 167 0.5× 114 0.4× 88 1.9k
Xueyuan Bai China 27 846 1.5× 226 0.5× 335 0.8× 327 1.0× 120 0.4× 77 1.9k
Liangming Liu China 25 940 1.7× 210 0.4× 227 0.6× 249 0.8× 204 0.8× 126 2.0k
Xiang Lü China 29 895 1.6× 374 0.8× 358 0.9× 417 1.3× 158 0.6× 80 2.2k

Countries citing papers authored by Xiaobing Ye

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Ye more than expected).

Fields of papers citing papers by Xiaobing Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Ye. The network helps show where Xiaobing Ye may publish in the future.

Co-authorship network of co-authors of Xiaobing Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Ye. A scholar is included among the top collaborators of Xiaobing Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Ye. Xiaobing Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Xiaobing, et al.. (2023). Bridge seismic fragility model based on support vector machine and relevance vector machine. Structures. 52. 768–778. 9 indexed citations
2.
Zhang, Zhengxiang, et al.. (2020). SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion. BioMed Research International. 2020(1). 8284576–8284576. 30 indexed citations
3.
Cai, Juan, Xueliang Zuo, Zhiqiang Chen, et al.. (2019). Long Noncoding RNAs Serve as Potential Diagnostic Biomarkers for Colorectal Cancer. Journal of Cancer. 10(3). 611–619. 18 indexed citations
4.
Song, Dongmei, Sun‐Zhong Mao, Xiaobing Ye, et al.. (2018). Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice. Atherosclerosis. 270. 68–75. 48 indexed citations
5.
Cai, Juan, Xueliang Zuo, Zhiqiang Chen, et al.. (2018). Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis. Cancer Management and Research. Volume 10. 1403–1412. 9 indexed citations
6.
Hua, Qingling, et al.. (2016). Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis. International Urology and Nephrology. 48(9). 1437–1443. 5 indexed citations
7.
Ye, Xiaobing, Hong Liu, Yongsheng Gong, & Shu Fang Liu. (2015). LPS Down-Regulates Specificity Protein 1 Activity by Activating NF-κB Pathway in Endotoxemic Mice. PLoS ONE. 10(6). e0130317–e0130317. 18 indexed citations
8.
Liu, Gang, Xiaobing Ye, Edmund J. Miller, & Shu Fang Liu. (2014). NF-κB-to-AP-1 Switch: A Mechanism Regulating Transition From Endothelial Barrier Injury to Repair in Endotoxemic Mice. Scientific Reports. 4(1). 5543–5543. 22 indexed citations
9.
Mao, Sun‐Zhong, Xiaobing Ye, Gang Liu, Dongmei Song, & Shu Fang Liu. (2014). An Obligatory Role of NF-κB in Mediating Bone Marrow Derived Endothelial Progenitor Cell Recruitment and Proliferation Following Endotoxemic Multiple Organ Injury in Mice. PLoS ONE. 9(10). e111087–e111087. 4 indexed citations
10.
Ye, Xiaobing, et al.. (2014). Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma. Journal of Molecular Histology. 45(4). 427–434. 17 indexed citations
11.
Cohen, Rubin I., et al.. (2013). Association of Nesfatin-1 and Fat Mass in Cystic Fibrosis. Respiration. 86(4). 312–317. 9 indexed citations
12.
Song, Dongmei, et al.. (2012). Chronic Intermittent Hypoxia Exposure Induces Atherosclerosis in ApoE Knockout Mice. American Journal Of Pathology. 181(5). 1530–1539. 40 indexed citations
13.
Wang, Baoshan, et al.. (2012). Chronic intermittent hypoxia down-regulates endothelial nitric oxide synthase expression by an NF-κB-dependent mechanism. Sleep Medicine. 14(2). 165–171. 36 indexed citations
14.
Ding, Jianqiang, Dongmei Song, Xiaobing Ye, & Shu Fang Liu. (2009). A Pivotal Role of Endothelial-Specific NF-κB Signaling in the Pathogenesis of Septic Shock and Septic Vascular Dysfunction. The Journal of Immunology. 183(6). 4031–4038. 77 indexed citations
15.
16.
Ye, Xiaobing, Jianqiang Ding, Xiaozhou Zhou, Chen Guo-qian, & Shu Fang Liu. (2008). Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsis. The Journal of Experimental Medicine. 205(6). 1303–1315. 167 indexed citations
17.
Ye, Xiaobing & Shu Fang Liu. (2006). Lipopolysaccharide causes Sp1 protein degradation by inducing a unique trypsin-like serine protease in rat lungs. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(2). 243–253. 15 indexed citations
18.
Greenberg, Harly, et al.. (2006). Chronic intermittent hypoxia activates nuclear factor-κB in cardiovascular tissues in vivo. Biochemical and Biophysical Research Communications. 343(2). 591–596. 187 indexed citations
19.
Cohen, Rubin I., et al.. (2003). Lipopolysaccharide down-regulates inducible nitric oxide synthase expression in swine heart in vivo. Biochemical and Biophysical Research Communications. 307(3). 451–458. 10 indexed citations
20.
Ye, Xiaobing, et al.. (1999). Inhibition of NF-κB Activation by Pyrrolidine Dithiocarbamate Prevents In Vivo Expression of Proinflammatory Genes. Circulation. 100(12). 1330–1337. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026